The escalating cost of healthcare in the United States is no longer simply a financial concern; for a growing number of Americans, it’s a geographic one. While headlines proclaim a wave of “medical tourism,” the reality is more complex – and more permanent – than a quick trip for a discounted procedure. A significant, though still relatively small, cohort is making the profound decision to relocate internationally, fundamentally altering their lives to access affordable and comprehensive medical care. This isn’t about seeking elective procedures; it’s about individuals with chronic conditions, facing impossible choices between treatment and financial ruin, finding viable long-term solutions abroad.
The story of Hilary Hodge exemplifies this trend. Suffering from severe allergic asthma since childhood, she found a potential treatment in biologic medication in 2012. However, the $36,000 annual cost in the U.S. rendered it inaccessible. This isn’t an isolated case; nearly half of American adults now express worry about affording medication or healthcare expenses, a figure that has steadily risen since data collection began in 2021, reaching a record high in 2025 according to a survey by West Health-Gallup Center for Healthcare in America. Hodge’s situation underscores a critical point often lost in discussions of healthcare policy: the price tag isn’t just a barrier to access, it’s a driver of emigration.
In 2017, Hodge and her husband initially moved to Algiers, France, for family reasons. But the immediate impact of healthcare costs was stark. The same biologic medication that cost $36,000 annually in the U.S. was available for $3,000 in France – a twelvefold difference. This wasn’t a temporary fix; the affordability allowed them to build a life in France, ultimately leading to a permanent relocation and the birth of their son. As Hodge succinctly put it to USA TODAY, “Health care is a big part of why” they stayed. This isn’t simply about cheaper medication; it’s about the peace of mind of not having to calculate deductibles against the severity of a life-threatening condition, like the adrenal crises she experiences. In the U.S., she describes a constant internal calculation: “Do I want to pay a $500 deductible to go to the hospital?” A calculation she doesn’t even consider in France.
The phenomenon extends beyond individual cases. Michelle Garabito, of the relocation service The Lux Nomads, reports a significant influx of clients seeking to leave the U.S. specifically for healthcare reasons. This isn’t limited to those with existing conditions. Leah Mark, who moved to Mallorca, Spain, from Indiana, cites stricter European Union food standards – bans on additives and preservatives common in American products – as a contributing factor to her improved well-being. This highlights a broader understanding of “health” that encompasses preventative care and environmental factors, areas where the U.S. often lags behind other developed nations. The appeal isn’t solely financial; it’s about a holistic shift towards a healthier lifestyle.
See the original USA Today story for the full account.
However, it’s crucial to avoid oversimplification. The narrative isn’t simply “America’s healthcare is broken, everyone is leaving.” Relocation is a complex undertaking, requiring legal navigation, logistical planning, and emotional adjustment. Obtaining the necessary visas – digital nomad visas or non-lucrative visas for retirees – can take months, and access to public healthcare systems is contingent upon legal residency. Garabito advises prospective expats to spend at least a month “trial running” life in a potential new country, experiencing the daily realities before making a permanent commitment. The process from visa approval to actual healthcare access typically takes three to six months.
Furthermore, the data on emigration driven by healthcare costs remains limited. While 38% of respondents in a recent American Expats Survey by The Harris Poll cited cheaper, better healthcare as a reason for considering expatriation, this represents a self-selected group already contemplating a move. It doesn’t reflect the broader population’s sentiment. The numbers are growing, but remain a fraction of the overall population. The true scale of “health-driven emigration” is difficult to quantify, and likely underestimated.
Looking ahead, the critical question isn’t if more Americans will consider moving abroad for healthcare, but where they will go and how the U.S. healthcare system will respond. Will the increasing pressure of emigration incentivize policy changes aimed at affordability and access? Or will the trend accelerate, creating a brain drain of individuals seeking a basic human right – affordable healthcare – elsewhere? The experiences of individuals like Hodge and Mark serve as a potent warning: the cost of inaction may be more than just financial; it may be the loss of citizens seeking a healthier, more secure future. We should be watching for legislative proposals addressing drug pricing and universal healthcare coverage, and analyzing whether these proposals demonstrably impact the rate of Americans seeking healthcare solutions beyond U.S. borders.
